SE427238B - Sett att isolera influensavirus-subenheter - Google Patents

Sett att isolera influensavirus-subenheter

Info

Publication number
SE427238B
SE427238B SE7500130A SE7500130A SE427238B SE 427238 B SE427238 B SE 427238B SE 7500130 A SE7500130 A SE 7500130A SE 7500130 A SE7500130 A SE 7500130A SE 427238 B SE427238 B SE 427238B
Authority
SE
Sweden
Prior art keywords
influencevirus
insulate
substances
insulate influencevirus
influencevirus substances
Prior art date
Application number
SE7500130A
Other languages
English (en)
Swedish (sv)
Other versions
SE7500130L (fr
Inventor
H Bachmayer
G Schmidt
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE7500130L publication Critical patent/SE7500130L/
Publication of SE427238B publication Critical patent/SE427238B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
SE7500130A 1974-01-14 1975-01-07 Sett att isolera influensavirus-subenheter SE427238B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (fr) 1974-01-14 1974-01-14

Publications (2)

Publication Number Publication Date
SE7500130L SE7500130L (fr) 1975-07-15
SE427238B true SE427238B (sv) 1983-03-21

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7500130A SE427238B (sv) 1974-01-14 1975-01-07 Sett att isolera influensavirus-subenheter

Country Status (27)

Country Link
JP (2) JPS58407B2 (fr)
AT (1) AT345449B (fr)
AU (1) AU500250B2 (fr)
BE (1) BE824372A (fr)
CA (1) CA1049406A (fr)
CH (1) CH589453A5 (fr)
CS (1) CS191254B2 (fr)
DD (1) DD116239A5 (fr)
DE (1) DE2500785B2 (fr)
DK (1) DK140003B (fr)
ES (1) ES433759A1 (fr)
FI (1) FI54053C (fr)
FR (1) FR2257305B1 (fr)
GB (1) GB1498261A (fr)
HK (1) HK56380A (fr)
HU (1) HU173920B (fr)
IE (1) IE40794B1 (fr)
IL (1) IL46426A (fr)
MY (1) MY8100204A (fr)
NL (1) NL166622C (fr)
NO (1) NO143128C (fr)
PH (1) PH14458A (fr)
PL (1) PL93689B1 (fr)
SE (1) SE427238B (fr)
SU (1) SU616997A3 (fr)
YU (1) YU41289B (fr)
ZA (1) ZA75259B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (fr) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccin dont l'adjuvant est constitué de sous-unités B de l'entérotoxine thermolabile (LTB) d'Escherichia coli
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
CN104474543A (zh) * 2005-11-01 2015-04-01 诺华疫苗和诊断有限两合公司 经由β-丙内酯处理的残留细胞DNA水平降低的细胞衍生病毒疫苗
RU2496519C2 (ru) * 2007-08-28 2013-10-27 Бакстер Интернэшнл Инк. Способ получения препарата, содержащего вирусные антигены, и применение препарата
JP6373376B2 (ja) 2013-11-15 2018-08-15 ノバルティス アーゲー 残留細胞培養不純物の除去

Also Published As

Publication number Publication date
CA1049406A (fr) 1979-02-27
HK56380A (en) 1980-10-16
FR2257305B1 (fr) 1982-03-19
JPS50100224A (fr) 1975-08-08
AU500250B2 (en) 1979-05-17
HU173920B (hu) 1979-09-28
IL46426A0 (en) 1975-04-25
PL93689B1 (fr) 1977-06-30
YU5875A (en) 1984-04-30
NO750031L (fr) 1975-08-11
IL46426A (en) 1978-01-31
JPS58407B2 (ja) 1983-01-06
FR2257305A1 (fr) 1975-08-08
SE7500130L (fr) 1975-07-15
NO143128B (no) 1980-09-15
FI750014A (fr) 1975-07-15
DE2500785A1 (de) 1975-07-31
ATA21475A (de) 1978-01-15
CS191254B2 (en) 1979-06-29
IE40794B1 (en) 1979-08-15
IE40794L (en) 1975-07-14
NO143128C (no) 1980-12-29
ZA75259B (en) 1976-08-25
DK1475A (fr) 1975-09-01
YU41289B (en) 1987-02-28
SU616997A3 (ru) 1978-07-25
NL166622C (nl) 1981-09-15
ES433759A1 (es) 1977-02-16
NL7500301A (nl) 1975-07-16
DD116239A5 (fr) 1975-11-12
CH589453A5 (fr) 1977-07-15
FI54053B (fi) 1978-06-30
DE2500785B2 (de) 1980-01-03
FI54053C (fi) 1978-10-10
NL166622B (nl) 1981-04-15
GB1498261A (en) 1978-01-18
AT345449B (de) 1978-09-11
DE2500785C3 (fr) 1980-09-11
JPS6035326B2 (ja) 1985-08-14
JPS56127319A (en) 1981-10-06
MY8100204A (en) 1981-12-31
PH14458A (en) 1981-07-29
AU7730575A (en) 1976-07-15
BE824372A (fr) 1975-07-14
DK140003C (fr) 1979-10-29
DK140003B (da) 1979-06-05

Similar Documents

Publication Publication Date Title
SE7512087L (sv) Sett att framstella vattensvellbar polyalkylenoxid
SE430887B (sv) Sett att framstella vissa substituerade fenylguanidiner
SE417507B (sv) Sett att framstella 2-arylamino-2-imidazolinderivat
SE420602B (sv) Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat
SE407944B (sv) Sett att framstella koks
IT1048346B (it) Procedimento per produrre stirolo
SE427238B (sv) Sett att isolera influensavirus-subenheter
SE399270B (sv) Sett att framstella spirolaktonsteroider
SE381252B (sv) Sett att framstella kontaktkroppar
SE7506037L (sv) Sett att framstella stabila kondensationsprodukter
SE427930B (sv) Sett att atervinna organotennhalogenider
SE7509513L (sv) Sett att framstella bietamidderivat
SE7508561L (sv) Sett att framstella alfa-azidobensylpenicillin
SE428471B (sv) Sett att framstella imidazolderivat
SE7506038L (sv) Sett att framstella stabila kondensationsprodukter
SE7506036L (sv) Sett att framstella stabila kondensationsprodukter
SE7506571L (sv) Sett att framstella nya bufatrienolidramnosideter
SE406316B (sv) Sett att framstella aluminiumoxidwhiskers
SE422336B (sv) Sett att framstella kiselstal
SE7510276L (sv) Borste jemte sett att framstella en sadan
JPS5118654A (ja) Kajitsuyowatsukusuno tofusochi
SE7514519L (sv) Sett att framstella laminatplattor
SE384967B (sv) Sett att framstella karieshemmande sackaros
SE7511825L (sv) Vermevexlartub och sett att framstella denna
JPS5139180A (ja) Hyosennoidootsuisekisuruhoho to sonosoochi

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7500130-5

Effective date: 19940810

Format of ref document f/p: F